Hematology NewsNew antibodies, drugs for refractory and relapsed myeloma are effective in patients over 65September 20, 2017Multiple MyelomaLymphoma & Plasma Cell Disorders
Hematology TimesTeam creates guidelines on CAR T-cell-related toxicitySeptember 20, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaAMLALLNon-Hodgkin LymphomaAggressive Lymphomas
Hematology TimesTrials of atezolizumab placed on partial holdSeptember 19, 2017Lymphoma & Plasma Cell DisordersMultiple MyelomaNon-Hodgkin LymphomaAggressive LymphomasFollicular Lymphoma
Hematology TimesApplication for pegfilgrastim biosimilar withdrawnSeptember 17, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaPharmacy
Hematology NewsIn Hodgkin lymphoma, HAPLO transplant outcomes match those of conventional transplantsSeptember 15, 2017Hodgkin LymphomaLymphoma & Plasma Cell Disorders
Hematology TimesFDA approves drug to treat relapsed FLSeptember 15, 2017Lymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin LymphomaAggressive LymphomasFollicular Lymphoma
Hematology TimesImmune status linked to outcomes of CAR T-cell therapySeptember 15, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersALLNon-Hodgkin LymphomaAggressive LymphomasFollicular Lymphoma
Hematology TimesSurvey reveals lack of specialized care for AYAs with cancerSeptember 15, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersHematology Nursing
Hematology NewsMost daratumumab infusion reactions occur in first infusionSeptember 14, 2017Multiple MyelomaLymphoma & Plasma Cell Disorders
Hematology TimesReport details progress, obstacles in cancer research and careSeptember 14, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaPediatricsRelated IssuesAMLALL
Hematology NewsKW-2478 examined as novel add-on therapy for myelomaSeptember 13, 2017Multiple MyelomaLymphoma & Plasma Cell Disorders
Hematology NewsBiosimilar matches rituximab in large follicular lymphoma trialSeptember 12, 2017Aggressive LymphomasLymphoma & Plasma Cell DisordersFollicular Lymphoma
Hematology TimesBiosimilar deemed equivalent to reference drug in FLSeptember 12, 2017Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive LymphomasFollicular Lymphoma
Hematology TimesStudy: Many cancer patients don’t understand clinical trialsSeptember 11, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaRelated Issues
Hematology TimesCCSs have higher burden of chronic conditionsSeptember 9, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersAMLALLHodgkin LymphomaNon-Hodgkin LymphomaAggressive Lymphomas
